Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318

In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of immunology 2000-10, Vol.30 (10), p.3012-3020
Hauptverfasser: Falk, Kirsten, Rötzschke, Olaf, Strominger, Jack L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3020
container_issue 10
container_start_page 3012
container_title European journal of immunology
container_volume 30
creator Falk, Kirsten
Rötzschke, Olaf
Strominger, Jack L.
description In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer.
doi_str_mv 10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72401071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72401071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4742-301c784b8ebaacc63d13d28112934c6050fd1492efd4eb1249acf4e1b0e77da33</originalsourceid><addsrcrecordid>eNqVkdtqGzEQhkVpaZy0r1B0VZKLdWckeQ9uKBj3EEOCCTgXvemg1WpdlT04Ky_FucojFPqGeZJqsZteldIrMdI__z-aj7FzhDECiDc4ERgpVHgqAADhTMIU4VwCiul0tngfLa6ubobqnRzDeL58K6LrJ2z02PaUjUKbikSWwhE79v5bsMniSfacHSFCnEE6GbEvs2br1rZ5uP_hN9a40hluK1e7Rm9d2_C25CtubFV57pqiN7bg-Y63lVu3te3cXai_2lqv11W_dY1r-OnF7IxLiB_uf0pMX7Bnpa68fXk4T9jNxw-r-UV0ufy0mM8uI6MSJaLwDZOkKk9trrUxsSxQFiJFFJlUJoYJlAWqTNiyUDZHoTJtSmUxB5skhZbyhL3e-2669ra3fku188PYurFt7ykRKqwwwX8KMUmkSDMIwtVeaLrW-86WtOlcrbsdIdAAiIZN07Bp2gMiOTzQgIQoAKLfgEgS0HxJgq6D7atDfp_XtvhjeiASBJ_3gu-usrv_Cv1L5uOd_AWBSKqZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17732890</pqid></control><display><type>article</type><title>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Falk, Kirsten ; Rötzschke, Olaf ; Strominger, Jack L.</creator><creatorcontrib>Falk, Kirsten ; Rötzschke, Olaf ; Strominger, Jack L.</creatorcontrib><description>In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/1521-4141(200010)30:10&lt;3012::AID-IMMU3012&gt;3.0.CO;2-Q</identifier><identifier>PMID: 11069085</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag GmbH</publisher><subject>Anergy ; Antigens, Viral - immunology ; Antigens, Viral - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Biopolymers - pharmacology ; CD4-Positive T-Lymphocytes - drug effects ; CD4-Positive T-Lymphocytes - immunology ; Cells, Cultured ; Clonal Anergy ; Cluster ; Drug Evaluation, Preclinical ; Epitopes - immunology ; Epitopes - pharmacology ; Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins, Viral - immunology ; Hemagglutinins, Viral - pharmacology ; High zone tolerance ; Humans ; Immunophenotyping ; Influenza A virus - immunology ; influenza virus ; Lymphocyte Depletion - methods ; MHC ; Peptide Fragments - immunology ; Peptide Fragments - pharmacology ; Peptides - pharmacology</subject><ispartof>European journal of immunology, 2000-10, Vol.30 (10), p.3012-3020</ispartof><rights>2000 WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4742-301c784b8ebaacc63d13d28112934c6050fd1492efd4eb1249acf4e1b0e77da33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1521-4141%28200010%2930%3A10%3C3012%3A%3AAID-IMMU3012%3E3.0.CO%3B2-Q$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1521-4141%28200010%2930%3A10%3C3012%3A%3AAID-IMMU3012%3E3.0.CO%3B2-Q$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11069085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Falk, Kirsten</creatorcontrib><creatorcontrib>Rötzschke, Olaf</creatorcontrib><creatorcontrib>Strominger, Jack L.</creatorcontrib><title>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer.</description><subject>Anergy</subject><subject>Antigens, Viral - immunology</subject><subject>Antigens, Viral - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biopolymers - pharmacology</subject><subject>CD4-Positive T-Lymphocytes - drug effects</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Cells, Cultured</subject><subject>Clonal Anergy</subject><subject>Cluster</subject><subject>Drug Evaluation, Preclinical</subject><subject>Epitopes - immunology</subject><subject>Epitopes - pharmacology</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus</subject><subject>Hemagglutinins, Viral - immunology</subject><subject>Hemagglutinins, Viral - pharmacology</subject><subject>High zone tolerance</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Influenza A virus - immunology</subject><subject>influenza virus</subject><subject>Lymphocyte Depletion - methods</subject><subject>MHC</subject><subject>Peptide Fragments - immunology</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptides - pharmacology</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkdtqGzEQhkVpaZy0r1B0VZKLdWckeQ9uKBj3EEOCCTgXvemg1WpdlT04Ky_FucojFPqGeZJqsZteldIrMdI__z-aj7FzhDECiDc4ERgpVHgqAADhTMIU4VwCiul0tngfLa6ubobqnRzDeL58K6LrJ2z02PaUjUKbikSWwhE79v5bsMniSfacHSFCnEE6GbEvs2br1rZ5uP_hN9a40hluK1e7Rm9d2_C25CtubFV57pqiN7bg-Y63lVu3te3cXai_2lqv11W_dY1r-OnF7IxLiB_uf0pMX7Bnpa68fXk4T9jNxw-r-UV0ufy0mM8uI6MSJaLwDZOkKk9trrUxsSxQFiJFFJlUJoYJlAWqTNiyUDZHoTJtSmUxB5skhZbyhL3e-2669ra3fku188PYurFt7ykRKqwwwX8KMUmkSDMIwtVeaLrW-86WtOlcrbsdIdAAiIZN07Bp2gMiOTzQgIQoAKLfgEgS0HxJgq6D7atDfp_XtvhjeiASBJ_3gu-usrv_Cv1L5uOd_AWBSKqZ</recordid><startdate>200010</startdate><enddate>200010</enddate><creator>Falk, Kirsten</creator><creator>Rötzschke, Olaf</creator><creator>Strominger, Jack L.</creator><general>WILEY‐VCH Verlag GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200010</creationdate><title>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</title><author>Falk, Kirsten ; Rötzschke, Olaf ; Strominger, Jack L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4742-301c784b8ebaacc63d13d28112934c6050fd1492efd4eb1249acf4e1b0e77da33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anergy</topic><topic>Antigens, Viral - immunology</topic><topic>Antigens, Viral - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biopolymers - pharmacology</topic><topic>CD4-Positive T-Lymphocytes - drug effects</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Cells, Cultured</topic><topic>Clonal Anergy</topic><topic>Cluster</topic><topic>Drug Evaluation, Preclinical</topic><topic>Epitopes - immunology</topic><topic>Epitopes - pharmacology</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus</topic><topic>Hemagglutinins, Viral - immunology</topic><topic>Hemagglutinins, Viral - pharmacology</topic><topic>High zone tolerance</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Influenza A virus - immunology</topic><topic>influenza virus</topic><topic>Lymphocyte Depletion - methods</topic><topic>MHC</topic><topic>Peptide Fragments - immunology</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Falk, Kirsten</creatorcontrib><creatorcontrib>Rötzschke, Olaf</creatorcontrib><creatorcontrib>Strominger, Jack L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Falk, Kirsten</au><au>Rötzschke, Olaf</au><au>Strominger, Jack L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2000-10</date><risdate>2000</risdate><volume>30</volume><issue>10</issue><spage>3012</spage><epage>3020</epage><pages>3012-3020</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag GmbH</pub><pmid>11069085</pmid><doi>10.1002/1521-4141(200010)30:10&lt;3012::AID-IMMU3012&gt;3.0.CO;2-Q</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 2000-10, Vol.30 (10), p.3012-3020
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_72401071
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection)
subjects Anergy
Antigens, Viral - immunology
Antigens, Viral - pharmacology
Apoptosis
Apoptosis - drug effects
Biopolymers - pharmacology
CD4-Positive T-Lymphocytes - drug effects
CD4-Positive T-Lymphocytes - immunology
Cells, Cultured
Clonal Anergy
Cluster
Drug Evaluation, Preclinical
Epitopes - immunology
Epitopes - pharmacology
Hemagglutinin Glycoproteins, Influenza Virus
Hemagglutinins, Viral - immunology
Hemagglutinins, Viral - pharmacology
High zone tolerance
Humans
Immunophenotyping
Influenza A virus - immunology
influenza virus
Lymphocyte Depletion - methods
MHC
Peptide Fragments - immunology
Peptide Fragments - pharmacology
Peptides - pharmacology
title Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T03%3A28%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antigen%E2%80%90specific%20elimination%20of%20T%20cells%20induced%20by%20oligomerized%20hemagglutinin%20(HA)%20306%E2%80%93318&rft.jtitle=European%20journal%20of%20immunology&rft.au=Falk,%20Kirsten&rft.date=2000-10&rft.volume=30&rft.issue=10&rft.spage=3012&rft.epage=3020&rft.pages=3012-3020&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/1521-4141(200010)30:10%3C3012::AID-IMMU3012%3E3.0.CO;2-Q&rft_dat=%3Cproquest_cross%3E72401071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17732890&rft_id=info:pmid/11069085&rfr_iscdi=true